The DOI matches its Crossref record; 47 of the 49 references it cites were found in a registry or an index.
A plasticity-based theory of the pathogenesis of Alzheimer's disease.
Abstract
Amyloid plaques (APs) and neurofibrillary tangles (NFTs) are the two diagnostic markers of Alzheimer's disease (AD). The neuropsychological features of AD are closely correlated with the distribution of the NFTs and therefore favor a disease process revolving around neurofibrillary degeneration. The genetics, however, favor a disease process revolving around the APs, principally because mutations in the amyloid precursor protein (A beta PP) are sufficient to cause AD. The inability to reconcile these two aspects of AD has prevented the formulation of a unified theory of pathogenesis. It is interesting to note that all genetic causes and risk factors of AD can increase the physiological burden of neuroplasticity. My hypothesis is that the resultant intensification of the plasticity burden leads to an initially adaptive upregulation of tau phosphorylation and A beta PP turnover, to the subsequent formation of NFTs and APs as independent consequences of excessive plasticity-related cellular activity, and to the eventual loss of neurons, dendrites, and synapses as the ultimate expression of plasticity failure. The two pathological markers of AD are therefore independent manifestations of a more fundamental process through which the many different genotypes of AD trigger an identical clinical and neuropathological phenotype.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This pattern is consistent with the hypothesis that AD pathology spreads centrifugally from limbic/paralimbic to higher-order association cortices (Mesulam, 2000).”
From Dynamics of Gray Matter Loss in Alzheimer's Disease (2003) · cites this paper as Mesulam, 2000
Citations
Cites
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.103 · Cited by 1,380
Amyloid, the presenilins and Alzheimer’s disease
Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370
Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives
Mattson, M. P. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.4.1081 · Cited by 1,006
Mechanisms of Neuronal Degeneration in Alzheimer's Disease
Yankner, B. A. (1996) · Neuron · doi:10.1016/s0896-6273(00)80115-4 · Cited by 953
Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice
Chapman, P. F., White, G. L., Jones, M. W., Cooper-Blacketer, D., Marshall, V. J., Irizarry, M., Younkin, L., Good, M. A., Bliss, T. V. P., Hyman, B. T., et al. (1999) · Nature Neuroscience · doi:10.1038/6374 · Cited by 946
Differential Effects of Apolipoproteins E3 and E4 on Neuronal Growth in Vitro
Nathan, B. P., Bellosta, S., Sanan, D. A., Weisgraber, K. H., Mahley, R. W., & Pitas, R. E. (1994) · Science · doi:10.1126/science.8171342 · Cited by 795
Research works printed but not linked: 2
- Masliah E. et al.1995. Abnormal synaptic regeneration in hAPP695 transgenic and APOE knockout mice.InResearch Advances in Alzheimer's Disease and Related Disorders. K. Iqbal J. A. Mortimer B. Winbladet al. Eds.: 406–414. John Wiley and Sons. New York.
- Trojanowski J.Q., 1993, From pathological marker to potential mediator of neuronal dysfunction and degeneration in Alzheimer's disease, Clin. Neurosci., 1, 184
Cited by
Sorted by citations
Items 101–130 of 130
A brain health framework with application to the study of neurodegeneration
Duchesne, S., Potvin, O., Hudon, C., & Bocti, C. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251364867 · Cited by 2
Topological Biomarker of Alzheimer’s Disease
Golubić, S. J. (2018) · InTech eBooks · doi:10.5772/intechopen.76633 · Cited by 2
Hypothesis: Entrapment of lipoprotein particles in the brain causes Alzheimer’s disease
Boche, D., & Nicoll, J. A. R. (2021) · Free Neuropathology · doi:10.17879/freeneuropathology-2021-3459 · Cited by 3
Alzheimer’s Disease: MRI Studies
Thompson, P. M., & Toga, A. W. (2009) · Elsevier eBooks · doi:10.1016/b978-008045046-9.00547-7 · Cited by 2
The Functional Neuroanatomy and Psychopharmacology of Predatory and Defensive Aggression
Peterson, J. B., & Shane, M. S. (2017) · Routledge eBooks · doi:10.4324/9781351322560-5 · Cited by 1
Transcranial Direct Current Stimulation for Neurodegenerative Disorders
Machado, S. E. D. C. (2016) · International Journal of Neurorehabilitation · doi:10.4172/2376-0281.1000e118 · Cited by 1
Blood Biomarkers of Cognitive Health and Neurodegenerative Disease
Mapstone, M. E., Gross, T. J., Subramaniam, S., Fiandaca, M. S., & Federoff, H. J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108552684.035 · Cited by 1
Brain Injury, Neural Plasticity, and Neuromodulation
Naro, A., & Calabrò, R. S. (2024) · Springer eBooks · doi:10.1007/978-3-031-63604-2_2 · Cited by 1
Brain functional connectivity in regions that exhibit age-related cortical thinning
Vieira, B. H. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.59.2018.tde-17042018-130342 · Cited by 1
A SCOPING REVIEW OF ALZHEIMER’S DISEASE HYPOTHESES: THE CASE FOR A MULTI-FACTORIAL THEORYPreprint
Duchesne, S., Rousseau, L., Belzile, F., Welsh, L.-A., Cournoyer, B., Arseneau, M., Lapierre, V., Poulin, S., Potvin, O., & Hudon, C. (2023) · medRxiv · doi:10.1101/2023.07.26.23293030 · Cited by 1
Roe, J. M., Dídac Vidal-piñeiro, A., Sørensen, Ø., Grydeland, H., Leonardsen, E. H., Iakunchykova, O. P., Pan, M., Mowinckel, A. M., Strømstad, M., Nawijn, L., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.09.559446 · Cited by 1
Fraser, L. M. (2013) · Library and Archives Canada (Government of Canada) · Cited by 1
Vianna, G. K., Reis, A. E. S., & de Carvalho, L. A. V. (2007) · Summer Computer Simulation Conference · doi:10.5555/1357910.1358031
Putative biomarkers of neuro-restoration in the CNS
Gnanapavan, S. (2013) · UCL Discovery (University College London)
Modulatory mechanisms of object-recognition memory in the perirhinal cortex
Gervais, N. J. (2014) · Spectrum Research Repository (Concordia University)
From neural transmission to genes
Hironaka, N. (2002) · Japanese Journal of Animal Psychology · doi:10.2502/janip.52.81
Development of nursing programme to assist medical treatment in early onset Alzheimer's disease
Ramström, I. (2012) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Khan, K. (2010) · Repository@Hull (Worktribe) (University of Hull)
Chapter 14 Deep Brain Stimulation for Memory Dysfunction
Ross, E. K., Bieniek, K. F., & Min, H.-K. P. (2016) · Pan Stanford Publishing eBooks · doi:10.1201/9781315364759-15
Saatchian, E., Ehsani, S., & Montazerabadi, A. (2020) · کومش · doi:10.29252/koomesh.22.4.671
Saccades in Alzheimer’s disease: an MRI study.
Wright, S. L. (2011) · Otago University Research Archive (University of Otago)
Lin, X., Chen, L., Baglietto‐Vargas, D., Ye, Q., LaFerla, F. M., Nitz, D. A., Holmes, T. C., & Xu, X. (2021) · Research Square · doi:10.21203/rs.3.rs-550358/v1
de Haan, W. (2012) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
Alzheimer’s disease as a syndrome of overloaded amyloidic synaptic tagging in memory networksPreprint
Murphy, N. (2021) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/7gsaz
Belviranlı, M., & Okudan, N. (2023) · Research Square · doi:10.21203/rs.3.rs-3034390/v1
Liang, X., Xue, C., Zheng, D., Yuan, Q., Qi, W., Ruan, Y., chen, S., Song, Y., Wu, H., Xiao, C., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3094289/v1
Neurodegenerative Disorders: Dementia and Parkinsonism, Lumping Together or Splitting Apart?
Merello, M., & Rossi, M. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6365-7_1
Duboisdindien, G. (2019) · theses.fr (ABES) · doi:10.70675/6821648cz8e25z4ee6zb599z489e8dc89766
Metadata
- Authors
- MESULAM, M. ‐.
- Affiliations
- Northwestern University (US)
- Corresponding author
- MESULAM, M.‐MARSEL
- ORCID
- MESULAM, M.‐MARSEL
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2000-12
- Volume
- 924
- Issue
- 1
- Pages
- 42-52
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W2061837100
- Cited by
- 130
- References
- 49
- Citations by year
- 2025: 2 · 2024: 5 · 2023: 7 · 2021: 6 · 2020: 3 · 2019: 8 · 2018: 4 · 2017: 4 · 2016: 7 · 2015: 5 · 2014: 7 · 2013: 8 · 2012: 10
- FWCI
- 0.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of the New York Academy of Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ns020285-15)
- National Institute on Aging (AG13854, P30AG013854)
- National Institute of Neurological Disorders and Stroke (NS 20285)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease pathogenesis, neuroplasticity, amyloid plaques, neurofibrillary tangles, tau phosphorylation, amyloid precursor protein, synaptic loss, neurodegeneration, genotype-phenotype correlation
- MeSH terms
- Alzheimer Disease, Brain, Humans, Neuronal Plasticity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review